Showing results (61-70 of 172) with videos related to

Sort By:
Pageof 18
Journal of Hepatology|February 27, 2013
The liver diseases of lipodystrophy: the long-term effect of leptin treatmentElika Safar Zadeh, Andreea O Lungu, Elaine K Cochran, et al.
Hepatology (Baltimore, Md.)|March 25, 2006
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infectionPonni Perumalswami, David E Kleiner, Glen Lutchman, et al.
Hepatology (Baltimore, Md.)|March 26, 2005
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophyEdward D Javor, Marc G Ghany, Elaine K Cochran, et al.
JAMA Network Open|April 10, 2023
Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North AmericaMandana Khalili, Kelsey R Leonard, Marc G Ghany, et al.
Hepatology (Baltimore, Md.)|June 29, 2007
Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for managementAnna S Lok, Fabien Zoulim, Stephen Locarnini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 13, 2014
Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adultsNaveen Gara, Adil Abdalla, Elenita Rivera, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2020
Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the badMarc G Ghany, Jordan J Feld, Kyong-Mi Chang, et al.
The Journal of Infectious Diseases|June 29, 2012
A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donorsRobert D Allison, Cathy Conry-Cantilena, Deloris Koziol, et al.
Case Reports in Hepatology|February 11, 2026
Exceptionally Long Recurrence-Free Survival in a Male Patient With Fibrolamellar Hepatocellular CarcinomaElizabeth C Townsend, Disha Sharma, Harish Gopalakrishna, et al.
The American Journal of Gastroenterology|June 23, 2026
PREVALENCE AND RISK FACTORS ASSOCIATED WITH MASLD AND ADVANCED FIBROSIS AMONG OVERWEIGHT INDIVIDUALS: IMPLICATIONS FOR SCREENING GUIDELINESMaria Mironova, Kaleb Tesfai, Egbert Madamba, et al.
Pageof 18